Skip to main content
HighlightsHighlights Archive

Government pledges nearly £1bn to boost innovation, growth and improve patient safety

By October 14, 2022No Comments

The Government have today announced an £800 million investment into research centres, to be allocated by the NIHR, and will bring together scientists to create an environment where experimental medicine, new diagnostics and patient safety research can thrive.

This boost to the country’s research infrastructure will see further investment in scientific expertise which supports access to innovative technology and novel research projects. As well as this, it will improve regional economic growth through employment opportunities, giving private sector organisations confidence to continue to invest in research across the country.

Nearly £790 million has been awarded to 20 NIHR Biomedical Research Centres (BRCs) across England – including a new centre in Exeter – over the next five years to drive innovation in the diagnosis and treatment of illness across a variety of high-priority disease areas including cancer, mental health and dementia. Around a third of that will be allocated outside of the Golden Triangle.

In addition, £25 million over the next five years has been awarded to six NIHR Patient Safety Research Centres (PSRCs) to help improve understanding and resolution of patient safety challenges. The funding will support research to improve incident reporting and investigations, digital innovations to improve patient safety and harness learning from service adaptation during the Covid pandemic.

Health and Social Care Secretary and Deputy Prime Minister Thérèse Coffey said: “The pandemic has highlighted the importance of our booming research sector and the potential it has to not only strengthen health and care services, but lead to lifesaving developments.

“This additional funding will harness the UK’s world-leading innovation and allow research centres up and down the country to attract experts in their field and conduct research that saves lives.”

Ben Kemp